Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Th17 cells in central nervous system autoimmunity.
Treatment with the Immunomodulator FTY720 (Fingolimod) Significantly Reduces Renal Inflammation in Murine Unilateral Ureteral Obstruction.
Multiple sclerosis: Spinal cord MRI reveals progression-related MS pathology.
Aquaporin-4 autoimmunity in a child without optic neuritis and myelitis.
Neuroinflammation and M2 microglia: the good, the bad, and the inflamed.
Gene expression profiling of the response to interferon Beta in epstein-barr-transformed and primary B cells of patients with multiple sclerosis.
Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron.
White matter disease: 'Bright spotty lesions'-a novel NMO-specific MRI feature?
[Co-authorship and collaboration networks in Spanish research into multiple sclerosis (1996-2010)].
Interactions of environment and genes in multiple sclerosis.
Dimethyl fumarate associated lymphopenia in clinical practice.
Multiple sclerosis following anti-tumor necrosis factor-alpha therapy for psoriasis: first case in Italy? Case report and review of the literature.
Increased relapse activity for multiple sclerosis natalizumab users who become nonpersistent: a retrospective study.
Dickkopf-3, a tissue-derived modulator of local T-cell responses.
Coping Among Individuals With Multiple Sclerosis: Evaluating a Goodness-of-Fit Model.
Drugs that Treat Skin Conditions May Help Combat Multiple Sclerosis.
Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders.
A diagnostic challenge in a young woman with intractable hiccups and vomiting: a case of neuromyelitis optica.
Molecular interplay between T-Antigen and splicing factor, arginine/serine-rich 1 (SRSF1) controls JC virus gene expression in glial cells.
Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions.
Postural control strategy during standing is altered in patients with multiple sclerosis.
Fertility treatment in spinal cord injury and other neurologic disease.
Reduced retinal nerve fiber layer thickness and macular volume in pediatric multiple sclerosis.
Live cell imaging techniques to study T cell trafficking across the blood-brain barrier in vitro and in vivo.
RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease?
Pages
« first
‹ previous
…
456
457
458
459
460
461
462
463
464
…
next ›
last »